← Back
M 10b5-1 Plan

$ Value

$0

Shares

7,402

Price

$0

Filed

Oct 22

Insider

Name

Stamoulis Christiana

Title

CIK

0001502917

Roles

Director

Transaction Details

Transaction Date

2025-10-20

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Transaction pursuant to an existing Rule 10b5-1 trading plan adopted February 19, 2025 to exercise and sell stock options expiring March 2, 2026. | Options became exercisable on the date of the 2017 Annual Meeting of Stockholders.

Filing Info

Accession No.

0000859737-25-000030

Form Type

4

Issuer CIK

0000859737

Stamoulis Christiana's History

Date Ticker Type Value
2026-04-07 HOLX D
2026-04-07 HOLX D
2026-04-07 HOLX D
2026-04-07 HOLX D
2026-04-07 HOLX D
2026-04-07 HOLX D
2026-04-07 HOLX D
2026-04-07 HOLX D
2026-04-07 HOLX D
2026-04-07 HOLX D

Other Insiders at HOLX (90d)

Insider Bought Sold Last
MACMILLAN STEPHEN P
Chairman, President and CEO
2026-04-07
Madaus Martin D 2026-04-07
Oberton Karleen Marie
Chief Financial Officer
2026-04-07
Dockendorff Charles J 2026-04-07
Wendell Amy McBride 2026-04-07
Stewart Stacey D. 2026-04-07
HANTSON LUDWIG 2026-04-07
Stamoulis Christiana 2026-04-07
COHN BENJAMIN JORDAN
Principal Accounting Officer
2026-04-07
McMillan Wayde D. 2026-04-07
Verstreken Jan
Group President, International
2026-04-07
Mitchell Essex D
Chief Operating Officer
2026-04-07
Schneiders Jennifer M
President, Diag. Solutions
2026-04-07
Mohtashami Nanaz 2026-04-07
Schnittker Brandon
President, GYN Surgical
2026-04-07
De Walt Diana
SVP, Human Resources
2026-04-07
Horvath Mark W.
President, Breast & Skeletal
2026-04-07
Liddy Anne M.
General Counsel
2026-04-07